M4MM

Organigram Reports Q1 Fiscal 2026 Financial Results

TORONTO – Organigram Global Inc. delivered a notable performance in its first quarter of fiscal 2026, posting substantial revenue increases and a return to profitability as the Canadian Cannabis producer continues to integrate recent acquisitions ...

Clearmind Featured in Bipartisan Veterans Therapy Bill

WASHINGTON D.C. – The recent introduction of bipartisan legislation in the U.S. House of Representatives has drawn attention to Clearmind Medicine Inc.'s proprietary compound MEAI as part of efforts to broaden veterans' access to certain ...

DOJ Keeps Silent on Cannabis Rescheduling Updates

WASHINGTON – It's been more than 40 days since President Donald Trump signed an executive order calling for the swift rescheduling of Cannabis, yet the Department of Justice (DOJ) remains tight-lipped on any progress. A ...

Subscribe To Our Newsletter